ST-246 Approval Status
FDA Approved: No
Brand name: ST-246
Company: SIGA Technologies, Inc.
Treatment for: Exposure to Smallpox Virus
ST-246 is an orally active, smallpox antiviral in development to treat individuals exposed to the smallpox virus in the event of an outbreak.
Development Status and FDA Approval Process for ST-246
|Apr 4, 2008||SIGA Initiates Manufacture of ST-246 NDA Registration Batches|
|Mar 24, 2008||SIGA Files Application Supporting Emergency Use Approval for ST-246|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.